Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-06-26
2007-06-26
Coleman, Brenda (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S284000
Reexamination Certificate
active
10088856
ABSTRACT:
A compound of formula (I) or a salt, ester, amide or prodrug thereof; where X is O, or S, S(O), S(O)2or NR6where R6is hydrogen of C1-6alkyl; R5is an optionally substituted 6-membered aromatic ring containing at least one nitrogen atom, and R1, R2, R3, R4are independently selected from halogeno, cyano, nitro, C1-3alkylsulphanyl, —N(OH)R7— (wherein R7is hydrogen, or C1-3alkyl), or R9X1— (wherein X1represents a direct bond, —O—, —CH2—, —OC(O), —C(O)—, —S—, —SO—, —SO2—, —NR10C(O)—, —C(O)NR11—, —SO2NR12—, —NR13SO2— or NR14— (wherein R10, R11, R12, R13and R14each independently represents hydrogen, C1-3alkyl or C1-3alkoxyC2-3alkyl), and R9is hydrogen, optionally substituted hydrocarbyl, optionally substituted heterocyclyl or optionally substituted alkoxy; provided that at least one of R2or R3is other than hydrogen. These compounds inhibit aurora 2 kinase and are useful in the preparation of medicaments for the treatment of proliferative disease such as cancer.
REFERENCES:
patent: 5721237 (1998-02-01), Myers et al.
patent: 6258820 (2001-07-01), Uckun et al.
patent: WO 95/15758 (1995-06-01), None
patent: WO 99/35132 (1999-07-01), None
Keen Nicholas John
Mortlock Andrew Austen
AstraZeneca AB
Coleman Brenda
LandOfFree
Therapeutic quinazoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic quinazoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic quinazoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3835431